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ABSTRACT 
Diabetes mellitus is a heterogeneous metabolic disorder characterized by hyperglycaemia resulting from defective insulin 
secretion, resistance to insulin action or both.. The role of trace elements in some of the metabolic dysfunctions and their 
contributions in the development of vascular complications is not clear. Therefore, the present study investigates the 
relationship among diabetes mellitus, trace elements status, lipid profiles in the serum of 50 diabetes mellitus patients and 
healthy subjects. The serum level of Cu was increased, whereas, Zn, Mg and Ca levels were significantly decreased in diabetic 
patients as compared to the healthy subjects. The levels of total cholesterol (CHOL), triglyceride (TG) and low-density 
lipoprotein-cholesterol (LDL) were higher in diabetes mellitus in comparison to the healthy subjects. The mean value of high-
density lipoprotein cholesterol (HDL) was lower in diabetic patients. These findings may explain the role of impaired trace 
element status. 
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1. INTRODUCTION
Diabetes mellitus is characterized by absolute or relative 
deficiencies in insulin secretion and/or insulin action 
associated with chronic hyperglycemia and disturbances of 
carbohydrate, lipid and protein metabolism. Long-term 
vascular complications represent a major cause of 
morbidity and mortality in patients with diabetes mellitus. 
Metal ions are known to play an essential role in living 
systems, both in growth and in metabolism. Impaired 
metabolism of trace elements is observed in diabetic 
patients. It has been reported that the urinary excretion of 
calcium, zinc and magnesium is increased in two types of 
diabetes mellitus causing a decrease in blood levels of 
these elements from these patients (1, 2). Another study 
reported that the levels of zinc and magnesium were 
significantly lower while the level of copper was 
significantly higher in serum of patients with IDDM (3). In 
diabetes mellitus (DM), the disorders of carbohydrates, 
lipids and proteins metabolism play predominant role in 
diabetic complications. Hypercholesterolemia (CHOL) 
and hypertriglyceridemia (TG) are mostly observed and 
related largely to the degree of diabetic control (4). Serum 
HDL was reported to be low in diabetic patients of both 
types of DM (5). Hyperglycemia may alter lipoproteins to 
a form that promotes atherogenesis. Low-density 
lipoprotein-cholesterol (LDL) levels are frequently altered 
in diabetic patients. 
In the present study, the estimation of serum metals (Cu, 
Ca, Mg, and Zn) along with levels of cholesterol, 
triglyceride, LDL, and HDL were evaluated in patients 
with diabetes with the aim of defining biochemical 
mechanisms. 
2. MATERIALS AND METHODS
Intravenous blood (10mL) samples from fifty patients and 
healthy subjects were collected and made to clot before 
serum was separated by centrifuging at 5000 r/min for 20 
min. 
Each metal the serum samples were analyzed using a 
Hitachi atomic absorption spectrophotometer (Tokyo, 
Japan). Cholesterol, triglycerides, HDL and LDL were 
determined using a kit method on Microlab 300. 
3. STATISTICAL ANALYSIS
All values are expressed as mean ± SE. For comparison 
between the patient’s and healthy subjects. 
4. Results
The levels of Zn, Ca and Mg were significantly lower in 
the serum of patients as compared to the healthy subjects. 
Whereas, the levels of Cu were significantly higher in the 
serum, respectively, in comparison to the control subjects. 
The levels of cholesterol, triglyceride and LDL were 
higher in patients as comparison to the healthy subjects. 
The level of HDL was lower in diabetic patients.(Table1). 
Table (1) showed the results of serum trace metals in 
patients and healthy controls. Expressed as 
mean±standard deviation 
Trace Metals Healthy 
Subjects 
Patients 
Copper 94. 4±3.22 100.36±5.32 
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Zinc 77.81±4.22 67.71±2.11 
Magnesium 18.11±0.42 16.28±1.33 
Calcium 144.09±4.33 122.05±3.57 
cholesterol 4.16±0.33 4.93±0.45 
Triglyceride 1.03±0.9 1.44±0.15 
HDL 2.58±0.12 2.03±0.11 








Fig: 1 shows the increased copper level in patients and in 











Fig: 3 show the decreased magnesium level in patients and in 









Fig: 5 show the decreased cholesterol level in patients and in 
figure 6 increases level of triglyceride in patients as 
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Fig: 7 show the decreased HDL level in patients and in 





Trace elements have important physiological effects when 
present at concentrations other than those associated with 
classical toxicity or with extreme deficiency. There is 
accumulating evidence that the metabolism of several trace 
elements is altered in diabetes 
 
Mellitus (6, 7). Dysfunctional neuroendocrine–endocrine 
interactions contribute to the disturbances in trace element 
metabolism and cause severe complications in diabetes 
mellitus (8). The present results showed that the levels of 
zinc, calcium and magnesium decreased in the blood of 
both types of Diabetic (Table 1, Fig: 2, 3, 4). The loss of 
these minerals might be attributed to impaired absorption 
and the excess excretion of these metals in urine 
(glycosuria) in these patients, which may induce a 
deficiency or marginal state of these minerals in blood of 
diabetic patients (1, 2). The increase in the Cu levels (Table 
1, Fig: 1) in patients with Diabetic may attributed to 
hyperglycemia that may stimulate glycation and release of 
copper ions from copper-containing enzymes. These 
observations are supported by the findings that zinc, 
copper and magnesium have antioxidant activities because 
not only do they constitute the active sites and stabilize the 
conformation of several antioxidant enzymes, but they also 
compete for iron- and copper- binding sites and can 
provide protection against transition metal-mediated and 
free radical-induced injury (9). The decrease in Zn may 
potentiate the toxicity of other metals such as iron and 
copper. Zinc deficiencies in diabetics are associated with 
excess free-radical activity and the increased oxidation of 
lipids, damaging the heart, arteries, and other integral parts 
of the vascular system (10). An increase in Cu 
concentration has been linked to disorders in the structure 
of the arterial walls, stress, infection, and diabetes mellitus 
(11). The relationship between an increase in Cu 
concentration and the oxidation of low-density 
lipoproteins has been confirmed (12). As shown in Table 
1, fig: 5 -8, the levels of total CHOL, TG and LDL were 
lower in patients as compared to healthy subjects. It can be 
concluded that hyperglycemia in diabetes mellitus is 
associated with accelerated nonenzymatic glycation and 
oxidative stress. The impaired trace element metabolism of 
the present study may have a role in the pathogenesis and 
progression of Diabetes where the increase of copper level 
and decrease of zinc, calcium and magnesium levels may 
disturb the antioxidants. All these parameters may 
contribute in the development of vascular complications in 
diabetic patients. Lipid abnormalities are due to resistance 
to insulin and hyperglycemia which are decreased high 
density lipoprotein, and increased and, more small dense 
low density lipoprotein and elevated triglycerides (13). 
The outcome confirms that deficiency of some trace metals 
may play a vital role in the development of diabetes 
mellitus. In order to better understand the role of trace 
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